Fosun Pharma Received NMPA Approval for Wan Ti Le
February 26, 2025 | 17:33
Shanghai Fosun Pharmaceutical announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. , has received approval from the National Medical Products Administration for the New Drug Application for Tenapanor Hydrochloride Tablets.
Mobile Version